Early toxicities associated with a 3-week hypofractionated radiotherapy regimen do not raise initial safety concerns in women ...

Comparison of electron- and proton-based FLASH radiotherapy reveals remarkable similarity in reducing acute skin damage ...

Actinium Pharmaceuticals, Inc. (NYSE AMERICAN: ATNM) (Actinium or the Company), a pioneer in the development of targeted radiotherapies, today announced ATNM-400, a novel, non-PSMA targeting, first in ...

The development of advanced radiotherapy technologies has, in turn, resulted in an increased complexity of operations. Also, a high level of accuracy is needed at every step of the process to achieve ...

Adding adjuvant chemotherapy to radiotherapy did not lead to a significant survival benefit over radiotherapy alone in women ...

Results from the NRG Oncology GOG-0263 Phase III clinical trial testing the addition of cisplatin-based chemotherapy to ...

On one side, are over 12,000 men every year in the UK who have their lives cut short by prostate cancer. Families are ...

Mum-of-four Verity Stansfield, 35, was diagnosed with a stage four glioblastoma - the most aggressive type of cancer that ...

Actinium announced ATNM-400, a novel, non-PSMA targeting, first in class radiotherapy for prostate cancer utilizing the Actinium-225 ...

The past and the present merge gently, but not quite imperceptibly, when Karen Shuster speaks about her second son. Morris ...

A CANCER survivor is to be the VIP guest starter for an annual running event which raises funds for life-saving treatment. Donna Crous will launch the “Race for Life”, organised by the Jersey branch ...

• In advanced-stage HL, reduction of chemotherapy or radiotherapy after a negative interim PET scan is probably beneficial for overall survival. • Treatment escalation with rituximab after a positive ...